MolecuLight

Toronto, Canada Founded: 2013 • Age: 13 yrs
Point-of-care devices for wound bacterial assessment are provided.

About MolecuLight

MolecuLight is a company based in Toronto (Canada) founded in 2013.. MolecuLight has raised $43.2 million across 6 funding rounds from investors including Hayfin, Prosegur and Oxford Finance. The company has 49 employees as of May 27, 2025. MolecuLight operates in a competitive market with competitors including Kent Imaging, ARANZ Medical, Eykona Technologies, WoundVision and CutoSense, among others.

  • Headquarter Toronto, Canada
  • Employees 49 as on 27 May, 2025
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Moleculight Corp.
Operational Areas
Healthcare → Medical Devices & Diagnostics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $43.2 M (USD)

    in 6 rounds

  • Latest Funding Round
    $27.5 M (USD), Series D

    Jan 06, 2025

  • Investors
    Hayfin

    & 7 more

  • Employee Count
    49

    as on May 27, 2025

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of MolecuLight
Headcount 10-50
Employee Profiles 12
Employee Profiles
People
Anil Amlani
CEO at MolecuLight Inc
People
Greg Duncan
Regional Sales Manager
People
Danielle Dunham
Director Of Marketing And Product Management
People
Jeffrey Kirman
Director of Advanced Development

Unlock access to complete

Funding Insights of MolecuLight

MolecuLight has successfully raised a total of $43.2M across 6 strategic funding rounds. The most recent funding activity was a Series D round of $27.5 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 6
  • Last Round Series D — $27.5M
  • First Round

    (29 May 2014)

  • Investors Count 8
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2025 Amount Series D - MolecuLight Valuation

investors

Aug, 2024 Amount Series C - MolecuLight Valuation Export Development Canada , Prosegur
Aug, 2022 Amount Debt – Conventional - MolecuLight Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in MolecuLight

MolecuLight has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Hayfin, Prosegur and Oxford Finance. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Private debt investments are directed across multiple sectors.
Founded Year Domain Location
-
Founded Year Domain Location
Healthcare-focused venture capital is provided by iGan Partners.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by MolecuLight

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - MolecuLight

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Moleculight Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of MolecuLight

MolecuLight operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kent Imaging, ARANZ Medical, Eykona Technologies, WoundVision and CutoSense, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Near-infrared imaging solutions for wound care are provided.
domain founded_year HQ Location
3D scanning systems for wound care and orthotics are developed.
domain founded_year HQ Location
Portable 3D imaging systems for dermatological applications are provided.
domain founded_year HQ Location
Provides wound imaging software for accurate measurement and medical documentation.
domain founded_year HQ Location
Medical systems for wound treatment are developed and analyzed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Moleculight

Frequently Asked Questions about MolecuLight

When was MolecuLight founded?

MolecuLight was founded in 2013 and raised its 1st funding round 1 year after it was founded.

Where is MolecuLight located?

MolecuLight is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.

Is MolecuLight a funded company?

MolecuLight is a funded company, having raised a total of $43.2M across 6 funding rounds to date.

How many employees does MolecuLight have?

As of May 27, 2025, the latest employee count at MolecuLight is 49.

What does MolecuLight do?

MolecuLight was founded in 2013 in Toronto, Canada, as a provider of medical devices in the wound care sector. A handheld fluorescence imaging device, known as i:X, is offered for visualizing bacterial presence and distribution in skin and chronic wounds. The product was launched in 2015, enabling point-of-care assessment in clinical settings. Operations focus on fluorescence-based diagnostics for improved wound management.

Who are the top competitors of MolecuLight?

MolecuLight's top competitors include CutoSense, Kent Imaging and ARANZ Medical.

Who are MolecuLight's investors?

MolecuLight has 8 investors. Key investors include Hayfin, Prosegur, Oxford Finance, SWK Holdings, and BDC.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available